In vitro effects of prostaglandin E2 on cutaneous vascular smooth muscle in the dog and in man.
D000818:Animals; D001158:Arteries / Q000187:drug effects*; D002118:Calcium / Q000008:administration & dosage / Q000494:pharmacology; D002196:Capillaries / Q000187:drug effects; D002395:Catecholamines / Q000494:pharmacology*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects*; D009638:Norepinephrine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011453:Prostaglandins / Q000008:administration & dosage / Q000494:pharmacology*; D012867:Skin / Q000098:blood supply*
D002395:Catecholamines; D011453:Prostaglandins; D011433:Propranolol; D002118:Calcium; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine